NAMS
Price
$26.73
Change
+$0.06 (+0.22%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
3B
54 days until earnings call
OCUL
Price
$12.55
Change
+$0.31 (+2.53%)
Updated
Sep 24, 04:59 PM (EDT)
Capitalization
2.13B
47 days until earnings call
Interact to see
Advertisement

NAMS vs OCUL

Header iconNAMS vs OCUL Comparison
Open Charts NAMS vs OCULBanner chart's image
NewAmsterdam Pharma
Price$26.73
Change+$0.06 (+0.22%)
Volume$14.02K
Capitalization3B
Ocular Therapeutix
Price$12.55
Change+$0.31 (+2.53%)
Volume$62.59K
Capitalization2.13B
NAMS vs OCUL Comparison Chart in %
Loading...
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAMS vs. OCUL commentary
Sep 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAMS is a Hold and OCUL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 25, 2025
Stock price -- (NAMS: $26.67 vs. OCUL: $12.25)
Brand notoriety: NAMS and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAMS: 48% vs. OCUL: 92%
Market capitalization -- NAMS: $3B vs. OCUL: $2.13B
NAMS [@Biotechnology] is valued at $3B. OCUL’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.36B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAMS’s FA Score shows that 1 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • NAMS’s FA Score: 1 green, 4 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, NAMS is a better buy in the long-term than OCUL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAMS’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 4 bullish TA indicator(s).

  • NAMS’s TA Score: 4 bullish, 4 bearish.
  • OCUL’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NAMS is a better buy in the short-term than OCUL.

Price Growth

NAMS (@Biotechnology) experienced а +8.77% price change this week, while OCUL (@Biotechnology) price change was -1.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.90%. For the same industry, the average monthly price growth was +10.70%, and the average quarterly price growth was +54.52%.

Reported Earning Dates

NAMS is expected to report earnings on Nov 17, 2025.

OCUL is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+4.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAMS($3B) has a higher market cap than OCUL($2.13B). OCUL YTD gains are higher at: 43.443 vs. NAMS (3.774). OCUL has higher annual earnings (EBITDA): -200.5M vs. NAMS (-237.93M). NAMS has more cash in the bank: 739M vs. OCUL (391M). NAMS has less debt than OCUL: NAMS (328K) vs OCUL (76.9M). NAMS has higher revenues than OCUL: NAMS (64M) vs OCUL (56.7M).
NAMSOCULNAMS / OCUL
Capitalization3B2.13B141%
EBITDA-237.93M-200.5M119%
Gain YTD3.77443.4439%
P/E RatioN/AN/A-
Revenue64M56.7M113%
Total Cash739M391M189%
Total Debt328K76.9M0%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NAMSOCUL
RSI
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
45%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
50%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 20 days ago
75%
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 10 days ago
70%
Bearish Trend 8 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
55%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
NAMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GREZX9.560.04
+0.42%
GuideStone Funds Global Rl Est Secs Inv
CENTX14.27N/A
N/A
Centerstone Investors I
RGLAX27.66-0.03
-0.11%
American Funds Global Insight R-1
VRMCX61.73-0.19
-0.31%
Virtus KAR Mid-Cap Core R6
GITAX33.17-0.38
-1.13%
Goldman Sachs Technology Opps A

NAMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAMS has been loosely correlated with QURE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if NAMS jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAMS
1D Price
Change %
NAMS100%
-1.40%
QURE - NAMS
56%
Loosely correlated
-1.23%
CRDF - NAMS
41%
Loosely correlated
-1.45%
BEAM - NAMS
39%
Loosely correlated
-2.79%
OCUL - NAMS
38%
Loosely correlated
+0.41%
XNCR - NAMS
37%
Loosely correlated
-0.67%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+0.41%
EYPT - OCUL
65%
Loosely correlated
+0.22%
NRIX - OCUL
56%
Loosely correlated
-2.25%
IDYA - OCUL
56%
Loosely correlated
+0.04%
CRNX - OCUL
55%
Loosely correlated
+6.35%
IMVT - OCUL
55%
Loosely correlated
-4.43%
More